MSN Laboratories Unclassified
FDA Approved Drugs

MSN Laboratories Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 29
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
287
View
Unclassified
29
View
Discontinued
6
View
RX
252
View
Company Overview

Company

MSN Laboratories Unclassified

Country

India

Website

Visit Website

Email

api@msnlabs.com

Social Profiles

Company Snapshot

MSN Laboratories Unclassified

MSN House Plot No: C-24 Industrial Estate, Sanathnagar Hyderabad - 18 Telangana

India

www.msnlabs.com/ api@msnlabs.com View on Map
FDA Approved Drug Records ( 29 records )
-
Unclassified Application: 216833

Drug Name

ACALABRUTINIB

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

216833 / 1

Active Ingredient

ACALABRUTINIB

Application Number

216833

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210212

Drug Name

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG/500MG

Approval Date

-

210212 / 1

Active Ingredient

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

210212

Product Number

1

Dosage Form

-

Strength

12.5MG/500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210212

Drug Name

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

12.5MG/1000MG

Approval Date

-

210212 / 2

Active Ingredient

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

210212

Product Number

2

Dosage Form

-

Strength

12.5MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210805

Drug Name

LEVOMILNACIPRAN

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

-

210805 / 1

Active Ingredient

LEVOMILNACIPRAN

Application Number

210805

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210805

Drug Name

LEVOMILNACIPRAN

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

-

210805 / 2

Active Ingredient

LEVOMILNACIPRAN

Application Number

210805

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210805

Drug Name

LEVOMILNACIPRAN

Product Number

3

Dosage Form

-

Strength

80MG

Approval Date

-

210805 / 3

Active Ingredient

LEVOMILNACIPRAN

Application Number

210805

Product Number

3

Dosage Form

-

Strength

80MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210805

Drug Name

LEVOMILNACIPRAN

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

-

210805 / 4

Active Ingredient

LEVOMILNACIPRAN

Application Number

210805

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219248

Drug Name

LUMATEPERONE TOSYLATE

Product Number

1

Dosage Form

-

Strength

10.5MG

Approval Date

-

219248 / 1

Active Ingredient

LUMATEPERONE TOSYLATE

Application Number

219248

Product Number

1

Dosage Form

-

Strength

10.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219248

Drug Name

LUMATEPERONE TOSYLATE

Product Number

2

Dosage Form

-

Strength

21MG

Approval Date

-

219248 / 2

Active Ingredient

LUMATEPERONE TOSYLATE

Application Number

219248

Product Number

2

Dosage Form

-

Strength

21MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219248

Drug Name

LUMATEPERONE TOSYLATE

Product Number

3

Dosage Form

-

Strength

42MG

Approval Date

-

219248 / 3

Active Ingredient

LUMATEPERONE TOSYLATE

Application Number

219248

Product Number

3

Dosage Form

-

Strength

42MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

1

Dosage Form

-

Strength

0.2MG

Approval Date

-

214367 / 1

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

1

Dosage Form

-

Strength

0.2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

-

214367 / 2

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

-

214367 / 3

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

4

Dosage Form

-

Strength

0.8MG

Approval Date

-

214367 / 4

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

4

Dosage Form

-

Strength

0.8MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

-

214367 / 5

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

6

Dosage Form

-

Strength

1.2MG

Approval Date

-

214367 / 6

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

6

Dosage Form

-

Strength

1.2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

7

Dosage Form

-

Strength

1.4MG

Approval Date

-

214367 / 7

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

7

Dosage Form

-

Strength

1.4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214367

Drug Name

SELEXIPAG

Product Number

8

Dosage Form

-

Strength

1.6MG

Approval Date

-

214367 / 8

Active Ingredient

SELEXIPAG

Application Number

214367

Product Number

8

Dosage Form

-

Strength

1.6MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216086

Drug Name

SITAGLIPTIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

216086 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

216086

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216086

Drug Name

SITAGLIPTIN

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

216086 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

216086

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216288

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

216288 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

216288

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216288

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

216288 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

216288

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217395

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

217395 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE

Application Number

217395

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217395

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

217395 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE

Application Number

217395

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217395

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

50MG

Approval Date

-

217395 / 4

Active Ingredient

SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE

Application Number

217395

Product Number

4

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219218

Drug Name

UBROGEPANT

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

219218 / 1

Active Ingredient

UBROGEPANT

Application Number

219218

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219218

Drug Name

UBROGEPANT

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

219218 / 2

Active Ingredient

UBROGEPANT

Application Number

219218

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211101

Drug Name

VORTIOXETINE HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

211101 / 2

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

211101

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211101

Drug Name

VORTIOXETINE HYDROBROMIDE

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

-

211101 / 3

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

211101

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    10 View
  • EDQM CEP
    121 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    13 View
  • NDC Database
    416 View
  • FDA Approved Drugs Database
    287 View
Drug Status Breakdown
29 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACALABRUTINIB

Application Number

216833

Product Number

1

Active Ingredient

ACALABRUTINIB

Dosage Form

-

Strength

100MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit